Cough, Cold and Allergy (Hay Fever) Remedies in Serbia

Cough, Cold and Allergy (Hay Fever) Remedies in Serbia

The weaker value growth seen in cough and cold, allergy (hay fever) remedies in 2024 can be attributed to falling inflation in Serbia and the lower incidence of coughs and colds at the beginning of 2024. Unit prices continued to rise in line with the arrival of several new launches in 2023-24. The leading brand Prospan has launched a new syrup flavour adapted specifically for adults. Fenistil also launched new packaging of its gel product.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.